Leadership at Vanderbilt-Ingram Cancer Center

The Vanderbilt-Ingram Cancer Center is led by a director, a deputy director, and team of associate center directors representing all aspects of the center. A Cancer Clinical Enterprise Committee oversees strategy and decision-making for the clinical operations of the center. Vanderbilt-Ingram Cancer Center is also guided by a volunteer community Board of Overseers and external scientific advisory board.

Executive Leadership Team

• Ben Ho Park, M.D., Ph.D.
  Director, Vanderbilt-Ingram Cancer Center
• Theresa M. Keske Sberna, M.P.H.
  Chief Business Officer; Deputy Director for Strategy and Analytics

Associate Directors

• Jordan D. Berlin, M.D.
  Associate Director for Clinical Research
• David K. Cortez, Ph.D.
  Associate Director for Basic Science Research
• Debra L. Friedman, M.D.
  Associate Director for Community Science and Health Outcomes
• Scott Hiebert, Ph.D.
  Associate Director for Shared Resources and Associate Director for Research Education
• Beth Jones, M.A.
• Executive Director of Development
• Tuya Pal, M.D.
  Associate Director for Cancer Health Disparities
• Xiao-Ou Shu, M.D., Ph.D.
• Associate Director for Global Health 
• Julie C. Schaum, M.S.
  Associate Director for Research Administration
• Yu Shyr, Ph.D.
  Associate Director for Quantitative Sciences
• Anne Washburn, M.P.H.
  Administrative Director for Community Relations and Affiliations
• Wei Zheng, M.D., Ph.D., M.P.H.
  Associate Director for Population-Based Research

Research Program Leaders

Breast Cancer Research Program

• Justin M. Balko, Pharm.D., Ph.D.
• Vandana G. Abramson, M.D.

Cancer Cell Biology Research Program

• Jin Chen, M.D., Ph.D.

Cancer Epidemiology Research Program

• Xiao-Ou Shu, M.D., Ph.D.
• Wei Zheng, M.D., Ph.D., M.P.H.

Cancer Health Outcomes and Control Research Program

• Debra L. Friedman, M.D.
• David F. Penson, M.D., M.P.H.

Gastrointestinal Cancer Research Program

• Cathy Eng, M.D.

Genome Maintenance Research Program

• David K. Cortez, Ph.D.
• William P. Tansey, Ph.D.

Host-Tumor Interactions Research Program

• Jeffrey Rathmell, Ph.D.
• John T. Wilson, Ph.D.

Translational Research and Interventional Oncology Research Program 

• Douglas Johnson, M.D., M.S.C.I.
• Christine M. Lovly, M.D., Ph.D.

Other Key Leaders

• Georgia Wiesner, M.D., M.S.
  Director, Clinical and Translational Hereditary Cancer Program

Executive Committee

• Ben Ho Park, M.D., Ph.D., Chair
• Ronald Alvarez, M.D., M.B.A.
• Dan Beauchamp, M.D.
• Jordan Berlin, M.D.
• Sam Chang, M.D., M.B.A.
• David K. Cortez, Ph.D.
• Nancy Davis, M.D.
• Debra L. Friedman, M.D.
• Laura Goff, M.D.
• Scott Hiebert, Ph.D.
• Kamran Idrees, M.D., M.S.C.I., M.M.H.C., FACS
• Beth Jones, M.A.
• Tuya Pal, M.D.
• David Penson, M.D., M.P.H., MMHC
• W. Kimryn (Kim) Rathmell, M.D., Ph.D.
• Brian Rini, M.D.
• Theresa M. Keske Sberna, M.P.H.
• Julie C. Schaum, M.S.
• Xiao-Ou Shu, M.D., Ph.D.
• Yu Shyr, Ph.D.
• Anne Washburn, M.P.H.
• Wei Zheng, M.D., Ph.D, M.P.H.
• Mary M. Zutter, M.D.